Martin Kenyon died peacefully aged 92 at home on Wednesday September 8.
Martin Kenyon speaking to CNN’s Cyril Vanier about his experience in receiving the vaccine at Guy’s Hospital in London
Mr Kenyon was interviewed on CNN in December 2020 outside Guy's Hospital where he had gone for a Covid jab on 'V-Day' and told the American reporter he'd turned up at the hospitalThe clip went viral and he was interviewed on GMTV the next day when he asked Piers Morgan:"Who are You?"Nina said they wanted to take him back to Shropshire, the county he loved and which loved him, before he died and said it was an emotional occasion.
"I think he knew it as well but one comfort is that it was fitting he would pass away peacefully at home the day before the Queen who he had met a number of times. He would have loved the significance of that."was attended by Archbishop Desmond TutuArchbishop Tutu met Mr Kenyon when he was studying at King's College London and the two were godfathers to their respective daughters.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Three Covid-19 deaths in Shropshire this week but end to the pandemic is 'in sight'People are still dying of coronavirus in Shropshire with three deaths in the county this week.
Read more »
A living WHO guideline on drugs for covid-19Updates This is the twelfth version (eleventh update) of the living guideline, replacing earlier versions (available as data supplements). New recommendations will be published as updates to this guideline. Clinical question What is the role of drugs in the treatment of patients with covid-19? Context The evidence base for therapeutics for covid-19 is evolving with numerous randomised controlled trials (RCTs) recently completed and under way. The emerging SARS-CoV-2 variants (such as omicron) and subvariants are also changing the role of therapeutics. This update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers, and janus kinase (JAK) inhibitors in patients with severe or critical covid-19, and modifies previous recommendations for the neutralising monoclonal antibodies sotrovimab and casirivimab-imdevimab in patients with non-severe covid-19. New or updated recommendations • Remdesivir: a conditional recommendation for its use in patients with severe covid-19; and a conditional recommendation against its use in patients with critical covid-19. • Concomitant use of IL-6 receptor blockers (tocilizumab or sarilumab) and the JAK inhibitor baricitinib: these drugs may now be combined, in addition to corticosteroids, in patients with severe or critical covid-19. • Sotrovimab and casirivimab-imdevimab: strong recommendations against their use in patients with covid-19, replacing the previous conditional recommendations for their use. Understanding the new recommendations When moving from new evidence to updated recommendations, the Guideline Development Group (GDG) considered a combination of evidence assessing relative benefits and harms, values and preferences, and feasibility issues. For remdesivir, new trial data were added to a previous subgroup analysis and provided sufficiently trustworthy evidence to demonstrate benefits in patients with severe covid-19, but not c
Read more »
Frontiers | COVID-19 patients exhibit unique transcriptional signatures indicative of disease severityCOVID-19 manifests a spectrum of respiratory symptoms, with the more severe often requiring hospitalization. To identify markers for disease progression, we analyzed longitudinal gene expression data from patients with confirmed SARS-CoV-2 infection admitted to the intensive care unit (ICU) for acute hypoxic respiratory failure (AHRF) as well as other ICU patients with or without AHRF and correlated results of gene set enrichment analysis with clinical features. The results were then compared with a second dataset of COVID-19 patients separated by disease stage and severity. Transcriptomic analysis revealed that enrichment of plasma cells (PCs) was characteristic of all COVID-19 patients whereas enrichment of interferon (IFN) and neutrophil gene signatures was specific to patients requiring hospitalization. Furthermore, gene expression results were used to divide AHRF COVID-19 patients into 2 groups with differences in immune profiles and clinical features indicative of severe disease. Thus, transcriptomic analysis reveals gene signatures unique to COVID-19 patients and provides opportunities for identification of the most at-risk individuals.
Read more »
Genomic sequencing reveals the course of COVID-19 in AfricaA new study explores the contribution of genomic sequencing to the scientific understanding of COVID-19, and on the introduction of global public health measures via the ability to pick up new variants early enough.
Read more »
Should You Get Your COVID-19 Booster and Flu Shot at the Same Time?Here's what experts say about getting the two vaccines at once
Read more »